Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-04-17 @ 3:10 PM
Study NCT ID:
NCT04346693
Status:
COMPLETED
Last Update Posted:
2021-10-13
First Post:
2020-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Sponsor:
Burnasyan Federal Medical Biophysical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
DAL-05-04-2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None